We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other Wednesday’s best ...

The acquisitions of Ambry Genetics and Deep 6 AI are expected to have contributed to Tempus AI's strategic expansion during the first quarter of 2025. The acquisition of Ambry Genetics ...

Doximity: Which AI in Healthcare Stock is a Better Buy?) In addition, the February 2025 acquisition of Ambry Genetics further expanded its genomics capabilities with a West Coast lab and enhanced ...

As US President Donald Trump takes aim at the Smithsonian Institution for "anti-American ideology", Adam Rutherford examines what the science of genetics has taught us about race. When scientists ...

In an opinion paper publishing March 27 in the Cell Press journal Trends in Genetics, Peifer explains how he incorporated a discussion of eugenics into his molecular genetics course last year and ...

All on news it just acquired Ambry Genetics, a well-known leader in genetic testing, for $600 million, which included $375 million in cash payments and $225 million in shares. Plus, Nancy Pelosi ...

New research has identified previously unknown genetic links to autism spectrum disorder (ASD), providing new insights into the genetic underpinnings of the condition. New research published in ...

Shares of Tempus AI TEM gained 18.4% after it announced an agreement, on Nov. 4, 2024, to acquire Ambry Genetics for $600 million. This acquisition will likely help Tempus revolutionize healthcare ...